An application of the C∗ concept in predicting the topical efficacy of finite dose acyclovir in the treatment of cutaneous HSV-1 infections in hairless mice-Reference-Cited by-同舟云学术

An application of the C∗ concept in predicting the topical efficacy of finite dose acyclovir in the treatment of cutaneous HSV-1 infections in hairless mice

Published:1993-05 Issue:1-3 Volume:93 Page:139-152
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Lee Paul H.,Su Muh-Hwan,Ghanem Abdel-Halim,Inamori Takeshi,Kern Earl R.,Higuchi William I.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference26 articles.

1. Susceptibility of HSV strains from patients with genital herpes treated with various formulations of acyclovir;Al-Hasani;J. Antimicrob. Chemother.,1986

2. The acute oral toxicity and primary ocular and dermal irritation of selected N-alkyl-2-pyrrolidones;Ansell;Food Chem. Toxicol.,1988

3. Limitations of hairless mouse skin as a model for in vitro permeation studies through human skin: hydration damage;Bond;J. Invest. Dermatol.,1988

4. Mechanism of action and selectivity of acyclovir. Acyclovir Symposium;Elion,1982

5. The biochemistry and mechanism of action of acyclovir;Elion;J. Antimicrob. Chemother.,1983

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of dermal bioavailability: predicting the input function for topical glucocorticoids using stratum corneum sampling;Drug Delivery and Translational Research;2021-10-01

2. Assessment of Drug Delivery Kinetics to Epidermal Targets In Vivo;The AAPS Journal;2021-03-29

3. Stratum Corneum Sampling to Assess Bioequivalence between Topical Acyclovir Products;Pharmaceutical Research;2019-11-14

4. Bioavailability and Bioequivalence of Dermatological Formulations;Dermatological and Transdermal Formulations;2002-02-20

5. Cutaneously applied acyclovir acts systemically in the treatment of herpetic infection in the hairless mouse;Antiviral Research;1997-08